Jianliang Shi - Concepedia

Author

Jianliang Shi

Bristol-Myers Squibb (United States)

Also Known As

Jian-Liang Shi, Jianliang Shi, Shi, Jianliang

Publications

215

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)

About

Jianliang Shi is an author at Bristol-Myers Squibb (United States) specializing in biochemistry, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	7	7	116
2	Medicine	6	6	104
3	Natural Sciences	6	6	103
4	Social Sciences	1	1	13
5	Cell Biology	1	1	30

Jianliang Shi

Publications

208

Citations

H-Index

Page 1

	Year	Citations
Development of New Benzenesulfonamides As Potent and Selective Na<sub>v</sub>1.7 Inhibitors for the Treatment of Pain Yong‐Jin Wu, Jason Guernon, Jianliang Shi, Journal of Medicinal Chemistry	2017	36
Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents Yong‐Jin Wu, Jason Guernon, Fukang Yang, ACS Medicinal Chemistry Letters Potent InhibitorNeurochemical BiomarkersBace1 Inhibitory ActivitySynaptic SignalingPre-clinical Pharmacology	2016	30
Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481 Kenneth M. Boy, Jason Guernon, Dmitry Zuev, ACS Medicinal Chemistry Letters	2019	22
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE) Kenneth M. Boy, Jason Guernon, Jianliang Shi, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2011	20
Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic Optimization Louis Chupak, Michael Wichroski, Xiaofan Zheng, ACS Medicinal Chemistry Letters	2023	18
BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder Lawrence R. Marcin, Jayakumar Warrier, Srinivasan Thangathirupathy, ACS Medicinal Chemistry Letters	2018	16
Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent γ-secretase inhibitors Michael G. Yang, Jianliang Shi, Dilip P. Modi, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPotent γ-Secretase InhibitorsPharmaceutical ScienceBiochemistryNatural Sciences	2007	15
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors Lorin A. Thompson, Jianliang Shi, Carl P. Decicco, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryVivo EvaluationMedicineNatural Sciences	2011	14
Identification and Preclinical Pharmacology of the<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi mathvariant="bold-italic">γ</mml:mi></mml:mrow></mml:math>-Secretase Modulator BMS-869780 Jeremy H. Toyn, Lorin A. Thompson, Kimberley A. Lentz, International Journal of Alzheimer s Disease Pharmaceutical ScienceNeurochemical BiomarkersPeptide ScienceSystem PharmacologyExperimental Pharmacology	2014	13
Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors Yong‐Jin Wu, Jason Guernon, Jianliang Shi, Journal of Medicinal Chemistry Drug TargetNeurochemical BiomarkersPharmacotherapyChemical BiologyPharmaceutical Chemistry	2016	12

Page 1